Literature DB >> 6177770

Inhibition of natural killer activity by human bronchoalveolar macrophages.

C Bordignon, F Villa, P Allavena, M Introna, A Biondi, R Avallone, A Mantovani.   

Abstract

Mononuclear phagocytes were isolated by adherence from peripheral blood, peritoneal exudates, early lactation milk, ovarian carcinomatous ascites and bronchoalveolar lavages. Their capacity to modulate natural killer (NK) activity was assessed by mixing them with blood lymphocytes and by measuring lysis of 51Cr-labeled K562 cells. Unlike other mononuclear phagocyte populations, alveolar macrophages caused a marked dose-dependent inhibition of NK activity. Significant inhibition (40%) of the expression of cytotoxicity was evident at a ratio of alveolar macrophages to lymphoid cells of 0.12:1, and more than 80% suppression was usually observed at a ratio of 0.5:1. Blood monocytes, peritoneal and milk macrophages were consistently inactive up to the highest ratio tested, 2:1. Inhibition of the expression of NK activity by alveolar macrophages was observed at lymphocyte to K562 ratios ranging from 6:1 to 100:1 and over a 4 h or 20 h 51Cr release assay. Alveolar macrophages also inhibited interferon-stimulated cytotoxicity. Alveolar macrophages are unique among the mononuclear phagocyte populations studied in their capacity to inhibit the expression of NK activity effectively, and they could play a role in determining the low levels of NK activity associated with human pulmonary tissue.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6177770

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Acute non-immunological inflammation inhibits natural killer (NK) activity in the lungs and enhances metastatic development.

Authors:  I Florentin; D Nolibe; J P Giroud
Journal:  Int J Exp Pathol       Date:  1991-02       Impact factor: 1.925

2.  Natural killer cells in intravenous drug abusers with lymphadenopathy syndrome.

Authors:  G Poli; M Introna; F Zanaboni; G Peri; M Carbonari; F Aiuti; A Lazzarin; M Moroni; A Mantovani
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

Review 3.  Tissue-specific effector functions of innate lymphoid cells.

Authors:  Niklas K Björkström; Eliisa Kekäläinen; Jenny Mjösberg
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

Review 4.  NK cells in immunotolerant organs.

Authors:  Haoyu Sun; Cheng Sun; Zhigang Tian; Weihua Xiao
Journal:  Cell Mol Immunol       Date:  2013-04-08       Impact factor: 11.530

Review 5.  Down-regulation of immune responses in the lower respiratory tract: the role of alveolar macrophages.

Authors:  P G Holt
Journal:  Clin Exp Immunol       Date:  1986-02       Impact factor: 4.330

6.  Host response to pulmonary fungal infections: A highlight on cell-driven immunity to Cryptococcus species and Aspergillus fumigatus.

Authors:  Orchi Dutta; Jorge A Masso-Silva; Keyi Wang; Amariliz Rivera
Journal:  Curr Pharmacol Rep       Date:  2017-10-14

7.  Human mononuclear phagocytes from different anatomical sites differ in their capacity to metabolize arachidonic acid.

Authors:  E Vicenzi; A Biondi; C Bordignon; A Rambaldi; M B Donati; A Mantovani
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

8.  Natural killer cells are present in the normal human lung but are functionally impotent.

Authors:  B W Robinson; P Pinkston; R G Crystal
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

Review 9.  Natural killer cells in infection and inflammation of the lung.

Authors:  Fiona J Culley
Journal:  Immunology       Date:  2009-10       Impact factor: 7.397

Review 10.  Natural killer cells in human solid tumors.

Authors:  M Introna; A Mantovani
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.